login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
Trillium Therapeutics Inc (TRIL.CA) Stock News
Canada
-
Toronto Stock Exchange
- TSX:TRIL -
23.33
+0.11 (+0.47%)
Last: 11/19/2021, 7:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TRIL.CA Latest News, Press Relases and Analysis
All
Press Releases
4 years ago - By: Trillium Therapeutics Inc.
- Mentions:
TRIL
Trillium Therapeutics Receives Final Court Order Approving Arrangement
4 years ago - By: Trillium Therapeutics Inc.
- Mentions:
TRIL
Trillium Securityholders Approve Acquisition by Pfizer
4 years ago - By: Bloomberg
- Mentions:
PFE
Pfizer to Acquire Cancer Drugmaker Trillium for $2.3 Billion
4 years ago - By: Pfizer Inc.
- Mentions:
PFE
TRIL
Pfizer to Acquire Trillium Therapeutics Inc.
5 years ago - By: BusinessInsider
Trillium Therapeutics Reports First Quarter 2021 Operating and Financial Results
5 years ago - By: BusinessInsider
Trillium Therapeutics to Host Virtual R&D Day for Investors on April 28, 2021
5 years ago - By: Bloomberg
- Mentions:
CRSP
VRTX
FATE
JNJ
...
Red-Hot Biotechs to Take Center Stage at Blood Disorder Meeting
5 years ago - By: BusinessInsider
- Mentions:
PFE
Trillium Therapeutics Reports Third Quarter 2020 Financial and Operating Results
5 years ago - By: Bloomberg
- Mentions:
PFE
GILD
FTSV
Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge
5 years ago - By: Bloomberg
- Mentions:
SII.CA
FVI.CA
NGD.CA
OSK.CA
...
Gold’s Rise Drives Canada Stock Benchmark in a New Direction
5 years ago - By: BusinessInsider
Trillium Therapeutics Reports Second Quarter 2020 Financial and Operating Results
Please enable JavaScript to continue using this application.